A Risk Stratification Model for Low Stage Uterine leiomyosarcoma - podcast episode cover

A Risk Stratification Model for Low Stage Uterine leiomyosarcoma

Jul 07, 202217 min
--:--
--:--
Listen in podcast apps:
Metacast
Spotify
Youtube
RSS

Episode description

Uterine leiomyosarcoma is the most common uterine mesenchymal malignancy. The majority present at stage I with variable clinical outcome.

In this episode of ModPath Chat, Dr. David Chapel discusses his recently published multi-institutional study proposing a novel risk stratification model (shown below) for low stage uterine leiomyosarcoma.

Risk score = (coagulative necrosis)(1) + (mitoses > 25 per 2.4mm2)(2) + (atypical mitoses)(2) + (lymphovascular invasion)(3) + (serosal abutment)(5)

For the best experience, listen in Metacast app for iOS or Android
Open in Metacast
A Risk Stratification Model for Low Stage Uterine leiomyosarcoma | ModPath Chat podcast - Listen or read transcript on Metacast